Cargando…

Association of circulating omentin level and metabolic-associated fatty liver disease: a systematic review and meta-analysis

BACKGROUND: Metabolic-associated fatty liver disease (MAFLD) is closely associated with omentin, a novel adipokine that plays a vital role in metabolic balance. The literature about the relationship between circulating omentin and MAFLD is conflicting. Therefore, this meta-analysis evaluated circula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qin, Chen, Shuaihang, Ke, Yani, Li, Qicong, Shen, Chenglu, Ruan, Yuting, Wu, Kaihan, Hu, Jie, Liu, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150062/ https://www.ncbi.nlm.nih.gov/pubmed/37139340 http://dx.doi.org/10.3389/fendo.2023.1073498

Ejemplares similares

Association of circulating vaspin levels and patients with metabolic-associated fatty liver disease: a systematic review and meta-analysis
por: Zhu, Yuqing, et al.
Publicado: (2022)

Clinical Utility of Circulating Pentraxin 3 as a Prognostic Biomarker in Coronavirus Disease 2019: A Systematic Review and Meta-analysis
por: Ke, Yani, et al.
Publicado: (2022)

Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis
por: Ke, Yani, et al.
Publicado: (2021)

Association of Plasma Omentin-1 Levels With Diabetes and Its Complications
por: Eimal Latif, Abdul Habib, et al.
Publicado: (2021)

The role of TRIM family in metabolic associated fatty liver disease
por: Zhang, Jingyue, et al.
Publicado: (2023)

Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study
por: Wang, Jun-Wei, et al.
Publicado: (2022)

Association of circulating omentin-1 level with lung cancer in smokers
por: Ansari, Mohammad Hassan Khadem, et al.
Publicado: (2018)

Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology
por: Peng, Dandan, et al.
Publicado: (2022)

Editorial: Interaction of endocrine disorders and metabolic associated fatty liver disease: the genetic and epigenetic basis
por: Pan, Qin, et al.
Publicado: (2023)

A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease
por: Yang, Chengzhang, et al.
Publicado: (2022)

Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults
por: Li, Hejun, et al.
Publicado: (2022)

Blood lactate levels are associated with an increased risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: a real-world study
por: Ma, Yi-Lin, et al.
Publicado: (2023)

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
por: Lee, Sejeong, et al.
Publicado: (2023)

Prevalence and associated factors of metabolic-associated fatty liver disease in overweight Finnish children and adolescents
por: Riekki, Hanna, et al.
Publicado: (2023)

Circulating omentin-1 might be associated with metabolic health status in different phenotypes of body size
por: Alizadeh, Shahab, et al.
Publicado: (2017)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease
por: Zhu, Cuiling, et al.
Publicado: (2022)

Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease
por: Xiao, Pei, et al.
Publicado: (2022)

Clinical Utility of Circulating Pneumoproteins as Diagnostic and Prognostic Biomarkers in COVID-19: A Systematic Review and Meta-analysis
por: Ke, Yani, et al.
Publicado: (2022)

Association of Circulating Omentin-1 with Osteoporosis in a Chinese Type 2 Diabetic Population
por: Yan, Pijun, et al.
Publicado: (2020)

Association between Chinese visceral adiposity index and metabolic-associated fatty liver disease in Chinese adults with type 2 diabetes mellitus
por: Tang, Min, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
por: Wen, Wen, et al.
Publicado: (2022)

Sex-specific prevalence and risk factors of metabolic-associated fatty liver disease among 75,570 individuals in eastern China
por: Chang, Mingxing, et al.
Publicado: (2023)

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2021)

Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
por: Lee, Chi-Ho, et al.
Publicado: (2023)

Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Liang, Chen, et al.
Publicado: (2022)

Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
por: Gao, Feng, et al.
Publicado: (2021)

Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults
por: Duan, Shaojie, et al.
Publicado: (2022)

The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease
por: Hu, Yingying, et al.
Publicado: (2023)

The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
por: Wei, Suosu, et al.
Publicado: (2023)

Editorial: Metabolic associated fatty liver disease: clinical perspectives from pathogenesis to diagnosis and treatment
por: Huang, Zhe, et al.
Publicado: (2023)

IRX3 plays an important role in the pathogenesis of metabolic-associated fatty liver disease by regulating hepatic lipid metabolism
por: Ma, Yongqiang, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome
por: Liu, Chia-Chu, et al.
Publicado: (2023)

J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes
por: Zhu, Cuiling, et al.
Publicado: (2022)

Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
por: Wang, Hongyan, et al.
Publicado: (2023)

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes
por: Chen, Congling, et al.
Publicado: (2023)

The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor
por: Zhang, Xiaofu, et al.
Publicado: (2020)

Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease
por: Delgado, Teresa C., et al.
Publicado: (2022)

Circulating omentin concentration increases after weight loss
por: Moreno-Navarrete, José María, et al.
Publicado: (2010)

Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis
por: Chai, Xiao-Ni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d211su1uihrhpee2hlhknsvtnj